These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32251416)

  • 21. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
    van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
    Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.
    Hyun JW; Huh SY; Shin HJ; Woodhall M; Kim SH; Irani SR; Lee SH; Waters P; Kim HJ
    Mult Scler; 2019 Apr; 25(4):585-590. PubMed ID: 29512413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Kim H; Lim YM; Kim G; Lee EJ; Lee JH; Kim HW; Kim KK
    J Neurol Sci; 2020 Aug; 415():116904. PubMed ID: 32446012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis.
    Müller J; Sinnecker T; Wendebourg MJ; Schläger R; Kuhle J; Schädelin S; Benkert P; Derfuss T; Cattin P; Jud C; Spiess F; Amann M; Lincke T; Barakovic M; Cagol A; Tsagkas C; Parmar K; Pröbstel AK; Reimann S; Asseyer S; Duchow A; Brandt A; Ruprecht K; Hadjikhani N; Fukumoto S; Watanabe M; Masaki K; Matsushita T; Isobe N; Kira JI; Kappos L; Würfel J; Granziera C; Paul F; Yaldizli Ö
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35217580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
    Zalewski NL; Morris PP; Weinshenker BG; Lucchinetti CF; Guo Y; Pittock SJ; Krecke KN; Kaufmann TJ; Wingerchuk DM; Kumar N; Flanagan EP
    J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):218-225. PubMed ID: 27913626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran.
    Barzegar M; Badihian S; Mirmosayyeb O; Ashtari F; Jamadi M; Emami S; Jahani L; Safavi A; Shaygannejad V
    Mult Scler Relat Disord; 2018 May; 22():161-165. PubMed ID: 29775851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.
    Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R
    Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
    Wang X; Yi H; Liu J; Li M; Mao ZF; Xu L; Peng FH
    J Neurol Sci; 2016 Jul; 366():3-7. PubMed ID: 27288767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enlarged choroid plexus related to cortical atrophy in multiple sclerosis.
    Chen X; Luo D; Zheng Q; Peng Y; Han Y; Luo Q; Zhu Q; Luo T; Li Y
    Eur Radiol; 2023 Apr; 33(4):2916-2926. PubMed ID: 36547675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Masuda H; Hirano S; Takahashi N; Hatsugano E; Uzawa A; Uchida T; Ohtani R; Kuwabara S; Mori M
    PLoS One; 2017; 12(8):e0184012. PubMed ID: 28846745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
    Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
    Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of diffusion-weighted imaging in patients with spinal cord infarction: difference from the findings of neuromyelitis optica spectrum disorder.
    Kobayashi M
    BMC Neurol; 2022 Oct; 22(1):382. PubMed ID: 36221057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait.
    Ismail II; Ahmed SF; Al-Hashel JY; Abdelnabi EA; Alroughani R
    Clin Neurol Neurosurg; 2020 Sep; 196():106047. PubMed ID: 32604036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.
    Huang C; Chen W; Liu B; Yu R; Chen X; Tang F; Liu J; Lu W
    Front Immunol; 2022; 13():897959. PubMed ID: 35774780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
    Chen X; Roberts N; Zheng Q; Peng Y; Han Y; Luo Q; Zeng C; Wang J; Luo T; Li Y
    Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Akaishi T; Takahashi T; Misu T; Abe M; Ishii T; Fujimori J; Aoki M; Fujihara K; Nakashima I
    Sci Rep; 2020 Aug; 10(1):13890. PubMed ID: 32807848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.